Everett Clinic oncologist Dr. Jason Lukas appeared on KING5’s New Day Northwest show to talk about our Providence Regional Cancer Partnership clinical trial program. The cancer partnership has 10 breast cancer trials and more than 40 other cancer-related trials underway.
Dr. Lukas is overseeing tests of the NeuVax breast cancer vaccine, which aims to decrease the recurrence of breast cancer in women. The breast cancer vaccine trial was also featured in the Sunday Herald. Read the article, “Providence tests vaccine against recurrence of breast cancer.”
“There's been vaccines tried for other types of solid tumors, but they haven't yet shown as much potential,” Dr. Lukas said. “This is the one where the data seem to be the most compelling.”
Lukas said he and another doctor first began exploring the idea of a vaccine to prevent some types of breast cancer recurrence while he was in the Navy.
Our Providence Regional Cancer Partnership works with a number of other medical facilities to administer these trials, including: University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and H. Lee Moffitt Cancer Center.
Dr. Lukas is board certified in internal medicine and oncology. He completed a fellowship in hematology/oncology at the University of California, San Francisco, and a residency in internal medicine at the University of Washington. He earned his PhD in the molecular biology of breast cancer at the University of Southern California.
Dr. Lukas is currently a Commander, Medical Corps, in the U.S. Navy returned from deploying as the Senior Medical Officer in Afghanistan from 2011 to 2012.
He is a member of the American Association for Cancer Research, the American College of Physicians, and the American Society of Clinical Oncology.
To learn more about the new breast cancer vaccine clinical trial, visit www.cancerpartnership.org/trials. To enroll in this clinical trial, call 425-297-5531.